Fatty liver disease (MASLD/MASH): open trials in Bulgaria

8 open trials have a site in Bulgaria. Registry data; only the trial team decides who can take part.

NCT06632444
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Trial Treatment · Phase 3 · Boehringer Ingelheim
Multiprofile Hospital For Active Treatment-Uni Hospital Ltd., Panagyurishte · University Multiprofile Hospital For Active Treatment St. Ivan Rilski EAD, Sofia · Military Medical Academy, Sofiya · Diagnostic-Consultative Center Alexandrovska EOOD, Sofiya · Acibadem City Clinic Tokuda University Hospital EAD, Sofiya · Medical Center New Rehabilitation Center EOOD, Stara Zagora · Meditsinski Tsentar Arkus Medikal A.D., Veliko Tarnovo
Registry updated 2026-10-28
NCT06632457
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Trial Treatment · Phase 3 · Boehringer Ingelheim
Multiprofile Hospital For Active Treatment-Uni Hospital Ltd., Panagyurishte · University Multiprofile Hospital For Active Treatment St. Ivan Rilski EAD, Sofia · Military Medical Academy, Sofiya · Acibadem City Clinic Tokuda University Hospital EAD, Sofiya · Diagnostic-Consultative Center Alexandrovska EOOD, Sofiya · Medical Center New Rehabilitation Center EOOD, Stara Zagora · Meditsinski Tsentar Arkus Medikal A.D., Veliko Tarnovo
Registry updated 2026-10-28
NCT06318169
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Trial Treatment · Phase 3 · Hoffmann-La Roche
Multiprofile Hospital For Active Treatment St. Ivan Rilski Gorna Oriahovitsa EOOD, Gorna Oryahovitsa · Diagnostic Consultative Centre Ascendent EOOD, Sofia · Diagnostic-Consultative Center Alexandrovska EOOD, Sofiya · Acibadem City Clinic Tokuda University Hospital EAD, Sofiya
Registry updated 2026-10-23
NCT06419374
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Trial Treatment · Phase 3 · Hoffmann-La Roche
Multiprofile Hospital For Active Treatment St. Ivan Rilski Gorna Oriahovitsa EOOD, Gorna Oryahovitsa · Diagnostic Consultative Centre Ascendent EOOD, Sofia · Acibadem City Clinic Tokuda University Hospital EAD, Sofiya · Umbal - Prof. D-R Stoyan Kirkovich AD, Stara Zagora
Registry updated 2026-10-23
2026-525755-82-00
A pivotal clinical study to investigate the safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis due to Metabolic dysfunction-associated steatohepatitis (MASH)
Trial Treatment · Phase 3 · Glaxosmithkline Research & Development Limited
Multiprofile Hospital For Active Treatment-Uni Hospital Ltd., Panagyurishte · Medical Centre Futuremeds EOOD, Plovdiv · Multiprofile Hospital For Active Treatment Hadji Dimitar OOD, Sliven · University Hospital Lozenetz, Sofia · Diagnostic Consultative Centre Ascendent EOOD, Sofia · Multispecialty hospital for active treatment Sveta Sofia EOOD, Sofiya · Acibadem City Clinic Tokuda University Hospital EAD, Sofiya · MBAL Trakia EOOD, Stara Zagora
Registry updated 2026-10-19
2026-525757-37-00
A study to investigate safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis (stage F4 fibrosis) due to MASH (NEBULA-2)
Trial Treatment · Phase 3 · Glaxosmithkline Research & Development Limited
Multiprofile Hospital For Active Treatment-Uni Hospital Ltd., Panagyurishte · Diagnostic Consultative Centre Ascendent EOOD, Sofia · University Hospital Lozenetz, Sofia · Multispecialty hospital for active treatment Sveta Sofia EOOD, Sofiya · MBAL Trakia EOOD, Stara Zagora
Registry updated 2026-10-19
NCT07165028
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Trial Treatment · Phase 3 · Eli Lilly and Company
Saint Marina Hospital, Pleven · UMHATEM N.I. Pirogov, Sofia · Medical Center - Arcus Medical, Veliko Tarnovo
Registry updated 2026-10-08
NCT07221188
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Trial Treatment · Phase 3 · GlaxoSmithKline
Multiprofile Hospital For Active Treatment St. Ivan Rilski Gorna Oriahovitsa EOOD, Gorna Oryahovitsa · Multiprofile Hospital For Active Treatment-Uni Hospital Ltd., Panagyurishte · University Multiprofile Hospital For Active Treatment Saint Georgi EAD, Plovdiv · Medical Centre Futuremeds EOOD, Plovdiv · Multiprofile Hospital For Active Treatment Hadji Dimitar OOD, Sliven · Diagnostic Consultative Centre Ascendent EOOD, Sofia · University Hospital Lozenetz, Sofia · Acibadem City Clinic Tokuda University Hospital EAD, Sofiya · University Multiprofile Hospital For Active Treatment And Emergency Medicine N I Pirogov, Sofiya · Military Medical Academy, Sofiya · Diagnostic-Consultative Center Alexandrovska EOOD, Sofiya · Multispecialty hospital for active treatment Sveta Sofia EOOD, Sofiya · Medical Center Hera EOOD, Sofiya · MBAL Trakia EOOD, Stara Zagora
Registry updated 2026-09-17

All Fatty liver disease (MASLD/MASH) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error